Cargando…
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores
INTRODUCTION: Osteoarthritis trials usually report average changes in visual analogue scale (VAS) pain, and examine the difference between treatment and placebo. We investigated whether dichotomous responder analysis provides a more informative interpretation of drug efficacy. METHODS: Merck supplie...
Autores principales: | Moore, R Andrew, Moore, Owen A, Derry, Sheena, McQuay, Henry J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453757/ https://www.ncbi.nlm.nih.gov/pubmed/18384679 http://dx.doi.org/10.1186/ar2394 |
Ejemplares similares
-
Pregabalin in fibromyalgia - responder analysis from individual patient data
por: Straube, Sebastian, et al.
Publicado: (2010) -
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2005) -
Correction: Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2006) -
Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2008) -
Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes
por: Moore, R Andrew, et al.
Publicado: (2008)